Clarity Pharmaceuticals Ltd has released a press release.
50% recruitment milestone for NET diagnostic Phase II trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Clarity Pharmaceuticals Ltd. on 6ix
Earlier from Clarity Pharmaceuticals
- PROPELLER Trial Results
- Diagnostic prostate cancer trial reaches recruitment target
- Positive topline results from SAR-bisPSMA diagnostic trial
- Managing Directors Presentation to AGM
- Chairmans Address to Shareholders
Later from Clarity Pharmaceuticals
- Clarity Corporate Presentation
- Clarity Receives $6.7 million R&D Tax Incentive Refund
- Theranostic prostate cancer trial advances to cohort 2
- Recruitment complete for Phase II prostate cancer trial
- Presentation at Jefferies Healthcare Conference
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals